Measuring Development of Brain Responses to Vocal Sounds in Babies of Mums With Mental Illness (CAPRI-Voc)

October 4, 2021 updated by: Kathryn Abel, University of Manchester

Children and Adolescents With Parental Mental Illness: Measuring Vocal Brain Development in Babies of Mothers Who Have Experienced Serious Mental Illness

CAPRI-Voc examines the differences in how speech and environmental sounds are processed in the infant brain as they grow from 9 to 12 months. The main aim of our research is to see whether serious mental illness or other factors influence this development in children. This means we are looking for new mums and their infants who have not experienced mental illness.

Study Overview

Status

Recruiting

Detailed Description

A delay in the development of language can make it hard for individuals to socialise and learn. While many children thrive, some children who live with a parent suffering from a mental illness develop difficulties with language and communication. Unfortunately, language delay is often missed until children are at school. By then, treatment options may be more limited and less effective. These children and their families would do better if they had more support early on. There is a lack of research in this area so we are cannot tell whether an individual child is at more risk or whether they have protective qualities. We need to know this to plan treatment and start it early because the earlier the help, the better the results.

Therefore, our study aims to identify children who will be most at risk of difficulties or delays in their language. It will also examine the effects of mental illness and other factors in mothers in the child's language and communication abilities. This will help us to design better treatments for the most at risk children because identifying them when they are infants means we can help their cognitive, development and language skills earlier.

To do this, we use a form of brain imaging called functional Near-Infrared Spectroscopy (fNIRS). It is a safe, non-invasive technique that records brain responses. When nerve cells in our brains are active, the supply of blood increases to those tissues. Our equipment detects these changes in blood flow by shining light onto the scalp. fNIRS has been safely used with thousands of infants worldwide. It is a common tool in neonatal and intensive care units and there are no side effects of fNIRS.

We ask your baby to put a cap on which has light sensors. Whilst baby has the cap on, we get them to watch 2 six-minute videos which have different sounds playing. Here, we will be able to see whether the baby can tell the difference between vocal sounds and environmental sounds (like traffic), as well as the differences in emotional speech (i.e. happy, sad and neutral speech).

As well as measuring baby's brain activity, we also ask mum questions about herself and video a 6-minute play session between mum and baby. Finally, we carry out a play session to measure baby's development. All assessments are done with the utmost care and mum is always present to make sure everyone is comfortable.

Study Type

Observational

Enrollment (Anticipated)

250

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Greater Manchester
      • Manchester, Greater Manchester, United Kingdom, M13 9PL
        • Recruiting
        • University of Manchester
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (ADULT, OLDER_ADULT, CHILD)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

We are interested in recruiting all women who have given birth since February 2021*

Please contact the our team if you have any questions about your suitability for the study.

Description

***If you have given birth in or after February 2021 and are interested in participating, please contact our research team.***

Inclusion Criteria:

  • Capacity to consent for themselves and their baby
  • Proficiency in English

Exclusion Criteria:

  • Women whose baby is permanently removed from their care
  • Women with a primary diagnosis of substance/alcohol abuse or dependence in the last year
  • Women with a primary diagnosis of anorexia/bulimia nervosa
  • Women with a primary diagnosis of a personality disorder, psychological development or somatoform disorders
  • Infants with congenital malformations, severe chronic illness, and developmental disorders

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Serious Mental Illness *RECRUITMENT IN THIS GROUP IS CLOSED

Mothers with a serious mental illness*

*received hospitalisation, treatment or intervention from a secondary care (mental health) service in the last 5 years.

Healthy Controls
Mothers with no history of mental illness, who have given birth since February 2021

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
functional near infrared spectroscopy (fNIRS) to assess changes in neural responses over time
Time Frame: When the child is 9 months and 12 months old

Baby will listen to vocal, non vocal, and emotional speech sounds for around 12 minutes. fNIRS uses near infrared light to capture changes in blood oxygenation in response to the sounds which is analogous to brain function.

We are only assessing brain responses to the auditory stimuli played, a video is used to keep the baby's attention on the task

When the child is 9 months and 12 months old

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Bayley scale of infant and toddler development III
Time Frame: When the child is 12 months old
A research tool involving standard series of measurements (games/tasks) to assess the cognitive and language development of children. This scale is designed to be used on children up to 3-4 years of age, therefore, the more tasks completed by a child the greater their cognitive or language ability.
When the child is 12 months old

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Kathryn M Abel, University of Manchester

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

September 1, 2017

Primary Completion (ANTICIPATED)

April 20, 2022

Study Completion (ANTICIPATED)

October 20, 2022

Study Registration Dates

First Submitted

April 6, 2020

First Submitted That Met QC Criteria

April 15, 2020

First Posted (ACTUAL)

April 17, 2020

Study Record Updates

Last Update Posted (ACTUAL)

October 12, 2021

Last Update Submitted That Met QC Criteria

October 4, 2021

Last Verified

October 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 212715

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mental Disorders, Severe

3
Subscribe